CDKN2A and colorectal carcinoma: Therefore, the aim of this study was to determine the association of EMAST with (i) clinicopathological features in colorectal carcinoma, (ii) MSI, (iii) CIMP and (iv) methylation of selected genes MSH3, MCC and CDKN2A (p16).